Related references
Note: Only part of the references are listed.Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S. Rao et al.
ANNALS OF ONCOLOGY (2021)
Volumetric Modulated Arc Therapy Improves Outcomes in Definitive Radiochemotherapy for Anal Cancer Whilst Reducing Acute Toxicities and Increasing Treatment Compliance
Jacqueline Possiel et al.
CANCERS (2021)
Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience
Krishan R. Jethwa et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2021)
Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma
Rebecca Shakir et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Management of anal cancer patients - a pattern of care analysis in German-speaking countries
Daniel Martin et al.
RADIATION ONCOLOGY (2020)
Patterns of care and outcomes of intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for anal cancer
Anna Lee et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Intensity Modulated Radiation Therapy Versus Conventional Radiation for Anal Cancer in the Veterans Affairs System
Alex K. Bryant et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Anal Carcinoma, Version 2.2018
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study
Joshua K. Elson et al.
CANCER (2018)
Utilization of intensity modulated radiation therapy for anal cancer in the United States
Waqar Haque et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
NRG Oncology/RTOG 0529: Long-Term Outcomes of Dose-Painted Intensity Modulated Radiation Therapy, 5-Fluorouracil, and Mitomycin-C in Anal Canal Cancer
L. A. Kachnic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
The Impact of Intensity Modulated Radiation Therapy on Hospitalization Outcomes in the SEER-Medicare Population With Anal Squamous Cell Carcinoma
Erqi L. Pollom et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529
Devarati Mitra et al.
ADVANCES IN RADIATION ONCOLOGY (2017)
Metabolic tumour volume of anal carcinoma on 18FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival
Siamak Mohammadkhani Shali et al.
EUROPEAN JOURNAL OF RADIOLOGY (2016)
Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Anal Cancer
Joseph C. Hodges et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis
Stefan Alexander Koerber et al.
RADIATION ONCOLOGY (2014)
RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal
Lisa A. Kachnic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2x2 factorial trial
Roger D. James et al.
LANCET ONCOLOGY (2013)
Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin
Leonard L. Gunderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)